Thrombosis
From the Journals
Study gives bleeding risk estimates for VTE patients on anticoagulants
New research provides best available estimates of long-term bleeding risk with different anticoagulants, authors say.
Conference Coverage
STOP-DAPT 2 ACS: 1 month of DAPT proves inadequate for patients with recent ACS
Findings from a Japanese trial show 1 month of dual antiplatelet therapy and 11 months of clopidogrel monotherapy is inferior to 12 months of DAPT...
Conference Coverage
ACST-2: Carotid stenting, surgery on par in asymptomatic patients
Periprocedural and 5-year outcomes were generally similar, but not all virtual attendees were convinced that either intervention is necessary in...
Conference Coverage
MASTER DAPT: 1 month DAPT enough after high-bleeding-risk PCI
The study gives the first prospective randomized evidence for abbreviated dual antiplatelet therapy in this group of patients with high risk for...
Conference Coverage
Eyes on ESC ‘21: Hope for EMPEROR-Preserved, guidelines remade
But the congress will feature far more than, potentially, results the heart failure world has been longing to see and a raft of new guidelines....
News
FDA approves Abbott’s Amplatzer Amulet for AFib
Long available in Europe, the approval heats up the U.S. market of minimally invasive solutions for stroke prevention with left atrial appendage...
From the Journals
‘Striking’ difference in adverse events in women with Watchman LAAO
National registry data show higher rates of major complications and death among women with atrial fibrillation with the preventive procedure.
News
Heparin’s COVID-19 benefit greatest in moderately ill patients
A multiplatform trial reported that therapeutic heparin improved outcomes in moderately ill COVID-19 patients but not in critically ill patients...
News
FDA panel balks at TriGuard 3 cerebral embolic device for TAVR
The device offers advantages over the approved Sentinel device but could not tamp down stroke rates, the very complication it was designed to...
Conference Coverage
DOACs best aspirin after ventricular ablation: STROKE-VT
Cerebrovascular protection was far better on DOACs after catheter ablation for VT or extrasystoles in the trial and may yet be further improved....
From the Journals
Direct oral anticoagulants: Competition brought no cost relief
Medicare Part D spending since 2011 has far outpaced growth in the use of oral anticoagulants.